葡萄球菌肠毒素M表现出类似于血栓的酶活性
Qian Huang1, Shuang-Hua Luo1, Wan-Fan Tian1
1College of Pharmacy and Food, Southwest Minzu University, Chengdu 610041, China.
Biomolecules
|October 29, 2025
概括
葡萄球菌肠毒素M (SEM) 意外地在特定的结合物上分裂,显示出内在的类似血栓激素 (TLA) 的活性. 这一发现得到了突变研究和模拟的证实,为了解SEM开辟了新的途径.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 蛋白质化学 蛋白质化学
背景情况:
- 葡萄球菌肠毒素M (SEM) 是一种已知的毒素.
- 再组合蛋白的表达通常涉及净化标签和裂变部位.
研究的目的:
- 使用固定金属亲和色谱 (IMAC) 来表达和净化葡萄球菌肠毒素M (SEM).
- 为了调查在再组合SEM融合蛋白的净化过程中观察到的意想不到的分裂事件.
主要方法:
- 使用IMAC和大小排除高性能液体染色学 (SE-HPLC) 进行重组蛋白表达和净化.
- N-终端测序和质谱测量用于识别裂变产物.
- AlphaFold 3结构预测和分子动力学 (MD) 模拟.
- 使用染色基质S-2238.8的酶分析.
主要成果:
- 一个重组的SEM融合蛋白质意外地在血栓分裂部位 (TCS) 内的Arg-Gly键上分裂.
- 结构分析揭示了SEM中的催化三位一体 (HSD),这表明内在的血栓状活性 (TLA).
- 一个关键的血清残留物的突变取消了TLA,证实了它的内在性质.
- 净化试验显示,特异性活性增加,支持TLA的存在.
结论:
- 野生类型的SEM结构具有内在的类似血栓激素的活性 (TLA),可以调节特定的Arg-Gly键裂变.
- 这种内在活动是独立于血栓酶,并源于SEM蛋白本身.
- 这些发现为了解SEM的TLA及其潜在影响提供了基础.
关键词:
阿尔法 折叠3 3他的6×-TCS-ΔNspSEMWT融合蛋白质染色基底 S-2238 染色基底固定化的金属亲和度色谱.分子动力学模拟,分子动力学模拟突变的His6×-TCS-ΔNspSEMS178A融合蛋白是一种突变的蛋白质.血清蛋白质酶三元体 (H172/S178/D212) 的使用.大小排除高性能液态色谱葡萄球菌肠内毒素M M血栓分裂部位序列 (LVPR ↓GS)它具有类似于血栓的活性.更多相关视频
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
1.0K
09:26Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
3.6K
相关概念视频
01:20Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K
01:16Clot Retraction and Fibrinolysis
8.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.4K